Trade Reporting Regimes

Global Trade ReportingTRAction Fintech is able to assist you with reporting requirements for the countries around the world where the financial services licensing regime requires Over-The-Counter (OTC) derivatives trades to be reported.

MiFID II and MiFIR

The upcoming changes to the European regulatory framework through the implementation of the Markets in Financial Instruments Directive (MiFID II) and the Markets in Financial Instruments Regulation (MiFIR) on 3 January 2018 will require firms to adapt their trade reporting processes.  TRAction Fintech has done the preparation for you so that you can stay compliant with trade reporting requirements through the transition.  Learn more about the changes here.

Trade Reporting Legislation

Global commitment to OTC derivatives reform arose out of the global financial crisis (GFC) in 2008. The GFC highlighted structural deficiencies in the global OTC derivatives markets and the systemic risk that those deficiencies posed to wider financial markets and the real economy.

In the lead-up to the GFC, those structural deficiencies contributed to the build-up of large counterparty exposures for which the risks were not appropriately managed. With details of OTC derivative transactions generally held only between the counterparties, in many cases those exposures were not transparent to other market participants and regulators.

OTC legislation

The overarching objectives of the OTC derivatives reforms are:

  • to enhance the transparency of transaction information available to relevant authorities and the public;
  • to promote financial stability; and
  • to support the detection and prevention of market abuse.

Australia Trade Reporting - ASIC

Find out more about the requirements for Australian OTC derivatives reporting under the ASIC regime. Read More


Singapore Trade Reporting - MAS

Find out more about the requirements for Singaporean OTC derivatives reporting under the MAS regime. Read More


European Trade Reporting - EMIR

Find out more about the requirements for Europe and the UK's OTC derivatives reporting. Read More